Your browser doesn't support javascript.
loading
Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic.
Kennedy, Nicholas A; Janjua, Malik; Chanchlani, Neil; Lin, Simeng; Bewshea, Claire; Nice, Rachel; McDonald, Timothy J; Auckland, Cressida; Harries, Lorna W; Davies, Merlin; Michell, Stephen; Kok, Klaartje B; Lamb, Christopher A; Smith, Philip J; Hart, Ailsa L; Pollok, Richard Cg; Lees, Charlie W; Boyton, Rosemary J; Altmann, Daniel M; Sebastian, Shaji; Powell, Nicholas; Goodhand, James R; Ahmad, Tariq.
Afiliação
  • Kennedy NA; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Janjua M; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.
  • Chanchlani N; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Lin S; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.
  • Bewshea C; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Nice R; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.
  • McDonald TJ; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Auckland C; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.
  • Harries LW; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.
  • Davies M; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.
  • Michell S; Department of Biochemistry, Exeter Clinical Laboratory International, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Kok KB; Department of Biochemistry, Exeter Clinical Laboratory International, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Lamb CA; Department of Microbiology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Smith PJ; Institute of Biomedical and Clinical Sciences, University of Exeter, Exeter, UK.
  • Hart AL; Institute of Biomedical and Clinical Sciences, University of Exeter, Exeter, UK.
  • Pollok RC; College of Life and Environmental Sciences, University of Exeter, Exeter, UK.
  • Lees CW; Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK.
  • Boyton RJ; Department of Gastroenterology, Royal London Hospital, Barts Health NHS Trust, The Royal London Hospital, London, UK.
  • Altmann DM; Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Sebastian S; Translational & Clinical Research Institute, Newcastle University Faculty of Medical Sciences, Newcastle upon Tyne, UK.
  • Powell N; Department of Gastroenterology, Royal Liverpool Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Goodhand JR; Department of Gastroenterology, St Mark's Hospital and Academic Institute, London, UK.
  • Ahmad T; Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London, UK.
Gut ; 72(2): 295-305, 2023 02.
Article em En | MEDLINE | ID: mdl-35902214

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Doenças Inflamatórias Intestinais / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Gut Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Doenças Inflamatórias Intestinais / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Gut Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido